Fat substitute gets FDA approvalBMJ 1996; 312 doi: https://doi.org/10.1136/bmj.312.7026.270a (Published 03 February 1996) Cite this as: BMJ 1996;312:270
- Terri L Rutter
The US Food and Drug Administration last week approved the controversial fat substitute Olestra. The move follows fears voiced by two professors from the Harvard School of Public Health that the product will cause long term detrimental health effects. Their fears in turn led a group of 30 public health specialists to write to the administration's commissioner, David Kessler, appealing to him to refuse approval.
Olestra, a mixture of sugar and vegetable oil, is a sucrose polyester made by attaching six or seven …
Log in using your username and password
Log in through your institution
Register for a free trial to thebmj.com to receive unlimited access to all content on thebmj.com for 14 days.
Sign up for a free trial